Good job. Read the part that I put in quotation marks. It's in latter stages of development. It's possible they drop pr about the change in billing to help their products sell better then BOOM drop one on Monday about test being a success. That could make it run like a marathon!! The review that led to the change in the pricing and billing structure for BREVAGenplus has also sharpened the Company's strategy with respect to other areas of its business. For example, the billing model designed for BREVAGenplus "can also be applicable to the Company's colorectal cancer (CRC) risk assessment test which is in the latter stages of development".
News 
Market Data 
Discover 
